| pubmed-article:2971553 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2971553 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:2971553 | lifeskim:mentions | umls-concept:C0920350 | lld:lifeskim |
| pubmed-article:2971553 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
| pubmed-article:2971553 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:2971553 | lifeskim:mentions | umls-concept:C1314939 | lld:lifeskim |
| pubmed-article:2971553 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:2971553 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:2971553 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
| pubmed-article:2971553 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:2971553 | pubmed:dateCreated | 1988-11-17 | lld:pubmed |
| pubmed-article:2971553 | pubmed:abstractText | Suppression of induced experimental autoimmune thyroiditis can be consistently transferred with spleen cells to syngeneic recipients, provided they are first treated with 200 rads irradiation. Treatment with anti-Thy-1 in vivo immediately prior to transfer abrogates the suppression, while depleting B cells has no effect. The in situ induced tolerance can be prevented by treatment with monoclonal antibodies to the Ly-1 or L3T4 molecules either prior to or post tolerization. Anti-Ly-2 treatment has no effect. In the transfer, again treatment of donors with anti-L3T4 prior to transfer prevents the demonstration of suppression in the recipients, while anti-Ly-2 does not affect suppression. These data suggest that the suppression is being mediated either by a CD4+ T suppressor cell or a CD4+ suppressor inducer cell. Preliminary experiments do not support the possibility of a CD8+ suppressor cell being activated in the recipient. | lld:pubmed |
| pubmed-article:2971553 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2971553 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2971553 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2971553 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2971553 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2971553 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2971553 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2971553 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2971553 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2971553 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:2971553 | pubmed:issn | 0014-2980 | lld:pubmed |
| pubmed-article:2971553 | pubmed:author | pubmed-author:CookeAA | lld:pubmed |
| pubmed-article:2971553 | pubmed:author | pubmed-author:RoittI MIM | lld:pubmed |
| pubmed-article:2971553 | pubmed:author | pubmed-author:ParishN MNM | lld:pubmed |
| pubmed-article:2971553 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2971553 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:2971553 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2971553 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2971553 | pubmed:pagination | 1463-7 | lld:pubmed |
| pubmed-article:2971553 | pubmed:dateRevised | 2009-9-29 | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:meshHeading | pubmed-meshheading:2971553-... | lld:pubmed |
| pubmed-article:2971553 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2971553 | pubmed:articleTitle | Phenotypic characteristics of cells involved in induced suppression to murine experimental autoimmune thyroiditis. | lld:pubmed |
| pubmed-article:2971553 | pubmed:affiliation | Department of Immunology, Middlesex Hospital Medical School, London, GB. | lld:pubmed |
| pubmed-article:2971553 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2971553 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2971553 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2971553 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2971553 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2971553 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2971553 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2971553 | lld:pubmed |
